Ken Watanabe

5PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Predictive factors for therapeutic response to radioactive iodine therapy in pulmonary metastases from differentiated thyroid carcinoma.

|Jan 11, 2024
Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.

Ken Watanabe, Takao Igarashi, Mayuki Uchiyama

|Sep 17, 2020
Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.

Ken Watanabe, Takao Igarashi, Mayuki Uchiyama

|Oct 03, 2018
Diagnostic value of ultrasonography and TI-201/Tc-99m dual scintigraphy in differentiating between benign and malignant thyroid nodules.

Ken Watanabe, Takao Igarashi, Hirokazu Ashida

|Jun 17, 2017
The outcome of I-131 ablation therapy for intermediate and high-risk differentiated thyroid cancer using a strict definition of successful ablation.

Ken Watanabe, Mayuki Uchiyama, Kunihiko Fukuda

Pageof 1

Frequent Collaborators